APA (7th ed.) Citation

Cramer, J. P., Dubischar, K., Eder, S., Burchard, G. D., Jelinek, T., Jilma, B., . . . Westritschnig, K. (2016). Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. Vaccine, 34(38), 4579-4585. https://doi.org/10.1016/j.vaccine.2016.07.029

Chicago Style (17th ed.) Citation

Cramer, Jakob P., Katrin Dubischar, Susanne Eder, Gerd D. Burchard, Tomas Jelinek, Bernd Jilma, Herwig Kollaritsch, Emil Reisinger, and Kerstin Westritschnig. "Immunogenicity and Safety of the Inactivated Japanese Encephalitis Vaccine IXIARO® in Elderly Subjects: Open-label, Uncontrolled, Multi-center, Phase 4 Study." Vaccine 34, no. 38 (2016): 4579-4585. https://doi.org/10.1016/j.vaccine.2016.07.029.

MLA (9th ed.) Citation

Cramer, Jakob P., et al. "Immunogenicity and Safety of the Inactivated Japanese Encephalitis Vaccine IXIARO® in Elderly Subjects: Open-label, Uncontrolled, Multi-center, Phase 4 Study." Vaccine, vol. 34, no. 38, 2016, pp. 4579-4585, https://doi.org/10.1016/j.vaccine.2016.07.029.